Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Kalinke

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 10, 2007
[After the TGN1412 incident. Principles for assessment of first-in-man trials with monoclonal antibodies by the Paul Ehrlich Institute]C K Schneider, U Kalinke
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 9, 1999
[Purpura pigmentosa progressiva in type III cryoglobulinemia and tartrazine intolerance. A follow-up over 20 years]D U Kalinke, B Wüthrich
Pneumologie (Stuttgart, Germany)|December 23, 2017
[Pulmonary Immune Mechanisms in Tuberculosis]C Herzmann, T Dallenga, U Kalinke
Nature|December 13, 1990
Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27U Kalinke, B Arnold, G J Hämmerling
The Journal of Investigative Dermatology|February 1, 1994
Collagen VII in severe recessive dystrophic epidermolysis bullosa: expression of mRNA but lack of intact protein product in skin and cutaneous cells in vitroD U Kalinke, U Kalinke, J O Winberg, et al.
Trends in Molecular Medicine|November 2, 2001
Immunity against prions?F L Heppner, I Arrighi, U Kalinke, et al.
Journal of Theoretical Biology|November 6, 1998
Mathematical model of a virus-neutralizing immunglobulin responseG A Funk, A D Barbour, H Hengartner, et al.
The Journal of Investigative Dermatology|September 1, 1997
A combination of a common splice site mutation and a frameshift mutation in the COL7A1 gene: absence of functional collagen VII in keratinocytes and skinN Hammami-Hauasli, D U Kalinke, H Schumann, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2007
Safety of phase I clinical trials with monoclonal antibodies in Germany--the regulatory requirements viewed in the aftermath of the TGN1412 disasterB Liedert, S Bassus, C K Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2000
Virus neutralization by germ-line vs. hypermutated antibodiesU Kalinke, A Oxenius, C Lopez-Macias, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 10, 2007
[After the TGN1412 incident. Principles for assessment of first-in-man trials with monoclonal antibodies by the Paul Ehrlich Institute]C K Schneider, U Kalinke
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 9, 1999
[Purpura pigmentosa progressiva in type III cryoglobulinemia and tartrazine intolerance. A follow-up over 20 years]D U Kalinke, B Wüthrich
Pneumologie (Stuttgart, Germany)|December 23, 2017
[Pulmonary Immune Mechanisms in Tuberculosis]C Herzmann, T Dallenga, U Kalinke
Nature|December 13, 1990
Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27U Kalinke, B Arnold, G J Hämmerling
The Journal of Investigative Dermatology|February 1, 1994
Collagen VII in severe recessive dystrophic epidermolysis bullosa: expression of mRNA but lack of intact protein product in skin and cutaneous cells in vitroD U Kalinke, U Kalinke, J O Winberg, et al.
Trends in Molecular Medicine|November 2, 2001
Immunity against prions?F L Heppner, I Arrighi, U Kalinke, et al.
Journal of Theoretical Biology|November 6, 1998
Mathematical model of a virus-neutralizing immunglobulin responseG A Funk, A D Barbour, H Hengartner, et al.
The Journal of Investigative Dermatology|September 1, 1997
A combination of a common splice site mutation and a frameshift mutation in the COL7A1 gene: absence of functional collagen VII in keratinocytes and skinN Hammami-Hauasli, D U Kalinke, H Schumann, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2007
Safety of phase I clinical trials with monoclonal antibodies in Germany--the regulatory requirements viewed in the aftermath of the TGN1412 disasterB Liedert, S Bassus, C K Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2000
Virus neutralization by germ-line vs. hypermutated antibodiesU Kalinke, A Oxenius, C Lopez-Macias, et al.
Pageof 3